Acrivon Therapeutics, Inc. Common Stock (ACRV) Insider Trading

Total insider buys:
  • $67,369,250.00
Total insider sells:
  • $3,045,577.21
Most recent insider trade:
  • April 30, 2025
Most active insider trader:
  • Perceptive Advisors Llc
Trader NameDateTitleAmountPriceTypeTotal Value
April 30, 2025Major Shareholder437,881$1.41Sell$617,412.21
April 28, 2025Major Shareholder215,283$1.56Sell$335,841.48
April 25, 2025Major Shareholder1,054,669$1.95Sell$2,056,604.55
April 11, 2024Major Shareholder2,353,000$8.50Buy$20,000,500.00
June 26, 2023Major Shareholder16$12.93Sell$206.88
June 14, 2023Major Shareholder893$12.13Sell$10,832.09
June 12, 2023Major Shareholder2,000$12.34Sell$24,680.00
Nov. 17, 2022Major Shareholder400,000$12.50Buy$5,000,000.00
Nov. 17, 2022Director3,389,500$12.50Buy$42,368,750.00
First«1 of 1»Last
  • Insiders are both buying and selling Acrivon Therapeutics, Inc. Common Stock stock.

  • The insider traders at Acrivon Therapeutics, Inc. Common Stock are: Ltd Chione, Perceptive Advisors Llc, and Ra Capital Management, L.P.

  • The most active insider trader at Acrivon Therapeutics, Inc. Common Stock is Ltd Chione with 4 trades.

  • Perceptive Advisors Llc has sold the most Acrivon Therapeutics, Inc. Common Stock stock with a total value of $3,627,270.45.

  • Ra Capital Management, L.P. has bought the most Acrivon Therapeutics, Inc. Common Stock stock with a total value of $84,737,500.00.

  • The most recent insider trade for Acrivon Therapeutics, Inc. Common Stock was on April 30, 2025.

  • The single biggest insider buy for Acrivon Therapeutics, Inc. Common Stock was from Ra Capital Management, L.P. with a total value of $42,368,750.00 on Nov. 17, 2022.

  • The single biggest insider sell for Acrivon Therapeutics, Inc. Common Stock was from Perceptive Advisors Llc with a total value of $2,056,604.55 on April 25, 2025.